Prof. Yulan Ren 任玉兰
Chief Physician, Professor
Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive surgery for gynecologic cancers, including endometrial, ovarian, cervical, and vulvar cancer, as well as uterine fibroids. Provides comprehensive care involving chemotherapy and targeted therapy.
Dr. Ren is a Chief Physician and Professor at Fudan University Shanghai Cancer Center with nearly 20 years of clinical experience in gynecologic oncology. In 2014, Dr. Ren was a visiting scholar at MD Anderson Cancer Center and Stanford University School of Medicine. Research funding includes grants from the National Natural Science Foundation and Shanghai Municipal Science and Technology Commission.
Professional roles
- Deputy Leader, Endometrial Cancer Group, Gynecologic Oncology Branch, Shanghai Medical Association
- Member, Gynecologic Oncology Branch, Shanghai Medical Doctor Association
- Young Committee Member, Gynecologic Oncology Branch, Shanghai Medical Association
- Young Editorial Board Member, Chinese Journal of Cancer
Name order: in Chinese the family name comes first (Ren Yulan). Papers usually list the name as Yulan Ren or Ren Y.
Selected publications
29 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- Adv Sci (Weinh), 2026 (senior author): The Characteristics of Tumor Microenvironment by the Single Cell Profile in Endometrial Cancer of no Specific Molecular Profile (NSMP) Subtype. PubMed 42902496
- J Cancer Res Clin Oncol, 2026 (senior author): The features and prognostic value of ARID1A mutation and protein expression in endometrial cancer of no specific molecular profile (NSMP) subtype: a retrospective study in a large Chinese cohort. PubMed 41826754
- Front Oncol, 2025 (senior author): Deep cervical stromal invasion predicts poor prognosis in patients with stage II endometrioid endometrial cancer: a two-centered retrospective study. PubMed 40083871
- BMC Cancer, 2024 (senior author): Clinical application of FIGO 2023 staging system of endometrial cancer in a Chinese cohort. PubMed 39026198
- Ann Transl Med, 2023 (first author): Efficacy and safety of apatinib in patients with recurrent uterine malignancy: a prospective, single-center, single-arm, phase 2 study. PubMed 36819505
- Int J Med Sci, 2021 (senior author): Promoter Methylation-mediated Silencing of the MiR-192-5p Promotes Endometrial Cancer Progression by Targeting ALX1. PubMed 34104082
- Arch Gynecol Obstet, 2021 (senior author): Clinical characteristics and risk factors of invasion in extramammary Paget's disease of the vulva. PubMed 32990781
- Gynecol Oncol, 2020 (senior author): A preoperative prediction model for predicting coexisting adnexa malignancy of patients with G1/G2 endometrioid endometrial cancer. PubMed 32847677
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion